Delivery of Nanoformulations for Cancer Diagnosis and Treatment

A special issue of Nanomaterials (ISSN 2079-4991). This special issue belongs to the section "Biology and Medicines".

Deadline for manuscript submissions: closed (31 December 2021) | Viewed by 495

Special Issue Editors


E-Mail Website
Guest Editor
Mathematics in Medicine Program, Houston Methodist Research Institute, Houston, TX 77030, USA
Interests: mathematical oncology; precision medicine; mathematical medicine
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Mathematics in Medicine Program, The Houston Methodist Research Institute, Houston, TX, USA
Interests: multiscale modeling; biostatistics; cancer; nanomedicine; infectious diseases; immunotherapy; PBPK

E-Mail Website
Assistant Guest Editor
Mathematics in Medicine Program, The Houston Methodist Research Institute, HMRI R8-122, 6670 Bertner Ave, Houston, TX 77030, USA
Interests: multiscale modeling; computational medicine; cancer; nanomedicine; immunology
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

We are editing a Special Issue for Nanomaterials on “Delivery of Nanoformulations for Cancer Diagnosis and Treatment.” Based on your expertise in the field, we would like to invite you to submit a manuscript (original research or review article) by 31 December 2021 for consideration for publication in this Special Issue.

Nanomaterials (ISSN 2079-4991) is an open access online journal of oncology, published monthly by MDPI, indexed in PubMed, Scopus, Web of Science, PMC, Embase, CAPlus, and many other databases. The focus of this Special Issue includes the development of novel nanoformulations for the diagnosis and/or treatment of cancer using animal models and/or mathematical/computational models.

We fully understand the difficulties arising from large-scale disruptions due to the COVID-19 outbreak. If you have any questions or concerns in relation to the impact of COVID-19 on your research, please don’t hesitate to contact us, and we will make efforts to accommodate your schedule.

We look forward to receiving your response.

Prof. Dr. Vittorio Cristini
Prof. Dr. Zhihui Wang
Guest Editors
Dr. Prashant Dogra
Assistant Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nanomaterials is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • nanomedicine
  • nanomaterials
  • cancer diagnosis
  • cancer therapeutics
  • mathematical modeling
  • molecular imaging

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop